Hoist Finance has entered into a forward flow agreement with an Italian financial institution. The total investment under the agreement is approximately EUR 90 million and spans over up to 18 months. The agreement is one of the first and larger forward flow contracts entered in the Italian market.
â€œOur company is building a strong and solid position as a fair and long-term partner to the European banking system. We are encouraged by the fact that more and more banks are turning to Hoist Finance to assist them with non-performing loans.
This agreement reaffirms our partnership with one of Europeâ€™s larger consumer banks and we are proud that they have put the trust in Hoist Finance to be their preferred partner when it comes to aiding them with non-performing unsecured consumer loans over the next year and a half. â€�, says JÃ¶rgen Olsson, CEO Hoist Finance.
For further information please contact:
Michel Fischier, Group Head of Investor Relations
Telephone: +46 (0)8 555 177 19
This information is information that Hoist Finance AB (publ) is obligated to make public pursuant to the EU Market Abuse Regulation (Sw. EU:s marknadsmissbruksfÃ¶rordning). The information was submitted for publication, through the agency of the contact person set out above, at 21.30 CET on 13 March 2018.
About Hoist Finance
Hoist Finance is a trusted debt restructuring partner to international banks and financial institutions. We are specialised in serving banks in handling non-performing loans, and supporting individuals in becoming debt free. Through expertise and rigorous compliance we earn the banksâ€™ trust. Through respect, honesty and fairness we earn the trust of our customers. For further information, please visit hoistfinance.com.
Latest posts by Jasmine Petters (see all)
- Research Details Developments in the Medical Device Technologies Market on Global Market Will Make a Huge Impact in Near Future - March 20, 2018
- Statement by Kelly M. Semrau, Senior Vice President Global Corporate Affairs, Communication and Sustainability at SC Johnson - March 20, 2018
- Animal Antibiotics Market Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone) Worth +4 Billion USD by 2021 - March 20, 2018